We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Brain Abnormalities Revealed in Late Preterm Infants Using MRI

By HospiMedica International staff writers
Posted on 17 Jun 2014
Infants born 32 to 36 weeks into gestation may have smaller brains and other brain defects that could lead to long-term developmental difficulties, according to a new imaging study. More...


A lot of the existing information on preterm birth and brain development has been gathered from studies of individuals born very preterm, or less than 32 weeks into gestation at birth.

For the new study, published online June 2014 in the journal Radiology, researchers in Australia focused on moderate and late preterm (MLPT) infants—those born between 32 weeks, zero days, and 36 weeks, six days, into gestation. MLPT babies account for approximately 80% of all preterm births and are responsible for much of the rise in the rates of preterm births over the last 20 years. In spite of this, up to now there have been no large-scale studies published on brain alterations linked with MLPT births that may offer clues into brain-behavior relationships in this group of children.

“In those very preterm babies, brain injury from bleeding into the brain or a lack of blood flow, oxygen or nutrition to the brain may explain some of the abnormal brain development that occurs,” said the study’s lead author, Jennifer M. Walsh, MBBCh, BAO., MRCPI, from the Royal Women’s Hospital (Melbourne, Australia). “However, in some preterm babies, there may be no obvious explanation for why their brain development appears slow compared with babies born on time.”

The researchers performed magnetic resonance imaging (MRI) scanning on 199 MLPT and 50 full-term-born infants (greater than 37 weeks gestation) between 38 to 44 weeks of gestation. They searched for symptoms of brain injury and compared the size and maturation of multiple brain structures in the two groups. Whereas injury rates were similar between the two groups, MLPT births were tied to smaller brain size at full-term-equivalent age. Furthermore, MLPT infants had less developed myelination in one part of the brain and more immature gyral folding compared with full term-born controls.

The findings suggest that MLPT births may disrupt the predicted course of brain growth that would normally occur in the last two or so months in utero, according to Dr. Walsh. “Given that brain growth is very rapid in the last one-third of pregnancy, it is perhaps not surprising that being born during this potentially vulnerable period may disrupt brain development,” she said.

The researchers are hoping to better determine the impact that moderate to late preterm birth has on the brain, so that they can then begin to try different treatments designed to enhance brain function and long-term outcome in these infants. “Medications, along with early intervention to help parents understand their baby’s needs, have been effective in helping very preterm babies catch up to their term-born peers,” Dr. Walsh said. “However, whether any of the existing treatments will help babies born between 32 and 36 weeks is unknown, as they have not been studied very much at all.”

The researchers plan to follow the infants in the study group through childhood to learn more about the relationship between brain abnormalities and later outcomes. They also are evaluating additional MRI information about brain structure and function in these children. “Understanding what problems they have and what might be causing them is the first step in trying to improve their long-term outcome,” Dr. Walsh said.

Related Links:

Royal Women’s Hospital



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.